Upgrades, downgrades, and outlook changes from major analysts.
Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.
3,519 total articles
Laidlaw Securities reaffirmed a Buy rating on Viking Therapeutics (VKTX) and set a $110 price target after the company reported fourth-quarter 2025 financial results and corporate updates. The firm highlighted clearer development paths for VK2735 in both subcutaneous and oral forms and noted Viking's strong cash position. The company also reported …
JPMorgan downgraded Valvoline to Underweight from Neutral and set a new price target of $35, even as it raised that target from $30. The bank expects the integration of 162 Breeze locations to compress margins in fiscal 2026 and to raise pre-tax interest costs, risks that it says will outweigh benefits from lower base oil prices. Valvoline recently…
JPMorgan on Thursday downgraded Kraft Heinz from Neutral to Underweight and reduced its price target to $22 from $24. The move follows a fourth-quarter 2025 earnings beat that was supported by favorable SG&A and tax items, but JPMorgan highlighted below-consensus 2026 organic sales and EPS guidance, ongoing North America volume declines, and potent…
JPMorgan upgraded MercadoLibre from Neutral to Overweight and increased its price target to $2,800 from $2,650. The bank cited a less aggressive competitive environment following Shopee’s take rate increase, reduced downside risk to 2026-27 consensus estimates, and an expectation that MercadoLibre can sustain over 30% growth in Brazil in Q4 2025. T…
Rothschild Redburn reduced its rating on Legend Biotech (LEGN) from Buy to Neutral and cut the firm's price target from $83.00 to $24.00 after identifying competitive risks to Carvykti at ASH 2025. The firm also trimmed its peak sales forecast for the drug to about $6 billion from roughly $10 billion. Other analysts have reacted with a range of adj…
Baird downgraded Inspire Medical Systems (NYSE:INSP) from Outperform to Neutral and reduced its price target to $74 from $130, citing reimbursement headwinds and a trimmed fiscal 2026 outlook. The stock, trading around $68.21, has lost more than 63% over the past year and sits just above its 52-week low. Despite a sizable Q4 2025 earnings beat, the…
Barclays moved Pegasystems (NASDAQ: PEGA) from Equalweight to Overweight and trimmed its price target to $48.00 from $67.00, citing the company’s positioning in complex business process software and progress integrating AI into its Blueprint product. The upgrade coincides with Pegasystems reporting stronger-than-expected fourth-quarter 2025 results…
B. Riley has initiated coverage of Fennec Pharmaceuticals (NASDAQ: FENC) with a Buy rating and set a $16.00 price target, arguing that the market underprices PEDMARK's commercial prospects despite strong margin and revenue growth expectations. The firm flagged several near-term catalysts in 1Q/1H26 and noted the company has repaid all outstanding c…
Jefferies downgraded Vertex Inc. (VERX) from Buy to Hold and reduced its price target to $16 from $28 after citing eroding underlying KPIs in the fourth quarter of 2025 and uncertainty around an upcoming CEO transition. The move comes even as Vertex reported a modest earnings and revenue beat for the period; the stock has fallen more than 71% over …
Keefe, Bruyette & Woods (KBW) raised its price objective on American International Group to $97 from $96 and retained an Outperform rating following the insurer's fourth-quarter 2025 results. The firm attributed the change to expectations for faster premium growth, stronger net investment income and larger reserve releases, and modestly increased i…
Evercore ISI reaffirmed an Outperform rating and a $330.00 price objective for Apple (AAPL) even as it expects the company to delay the planned March launch of Apple Intelligence 2.0. The firm says testing issues will push the initiative into a multi-stage rollout over the year, with some features possibly appearing by mid-year and a broader Siri r…
Stifel has maintained a Buy rating and a $114.00 price target on Marvell (MRVL) following the close of the company's roughly $540 million acquisition of XConn Technologies. The bank incorporates modest near-term expense and interest-income effects from the cash consideration while forecasting XConn-generated revenue beginning in fiscal Q3 2027 and …
Stifel initiated coverage of Sterling Construction (STRL) with a Buy rating and a $486 price target, pointing to the company's leading position in excavation and its revenue mix tied to AI, cloud, onshoring and e-commerce. The firm says more than half of Sterling's revenue is exposed to these secular growth themes. Concurrently, Sterling announced …
Evercore ISI lowered its price target on Humana Inc. to $180.00 from $260.00 while holding an "In Line" rating, citing concerns about margin pressure tied to rapid individual Medicare Advantage enrollment growth and a higher medical loss ratio. Humana's 2026 EPS guidance of more than $9 aligns with Evercore's estimate but is below Street consensus.…
Freedom Capital Markets moved STRATTEC Security (STRT) from Buy to Hold while lifting its 12-month price target to $93 from $91 following the company’s Q2 fiscal 2026 report. The quarter showed revenue and profitability gains, a stronger balance sheet and robust cash generation, but management signaled a more moderate second-half outlook tied to mi…
Stifel lowered its 12-month price target on Shopify to $115 from $175 while retaining a Hold rating. The revision follows Shopify's recent quarterly results showing robust revenue growth, enterprise wins and rising Payments penetration, but management's reduced first-quarter free cash flow margin guide and sector-wide weakness pressured the stock. …
DA Davidson has reaffirmed its Buy rating on Shopify with an unchanged $195.00 price target following the company’s robust finish to 2025. The firm highlights continued top-line momentum and expanding global reach, even as shares swung from an early gain to a midday decline amid concerns about near-term free cash flow and broader SaaS-sector pressu…
Truist Securities lifted its price target on SiteOne Landscape Supply to $200 from $165 while keeping a Buy rating. The new target implies about 23% upside from the stock's recent price, even as the shares trade at a relatively high P/E. SiteOne posted Q4 2025 results that slightly beat EPS estimates, delivered revenue in line with expectations, an…
Truist Securities reduced its price target on Shopify to $110 from $155 while retaining a Hold rating, pointing to broad valuation compression across its coverage universe even as Shopify reported stronger-than-expected fourth-quarter results. The updated target is close to the stock's current trading level, and analysts note both attractive medium…
B.Riley has lowered its 12-month price target for Builders FirstSource (BLDR) from $29.00 to $22.00, a 24% reduction, while keeping a Buy rating. The firm updated its target on Wednesday, February 11, 2026. Builders FirstSource shares are trading at $125.16 and sit between analyst targets ranging from $95 to $150. Several other brokerages have also…
Canaccord Genuity trimmed its price target on Shopify to $165 from $185 but left its Buy recommendation intact, citing persistent momentum in the business alongside investor questions about AI-driven disruption in software. The firm points to strong recent revenue growth and solid liquidity, while valuation measures remain elevated following the la…
BofA Securities reduced its price objective for Avantor Inc. to $11 from $13 while retaining a Neutral stance after the company issued softer-than-expected fiscal 2026 guidance. The adjustment follows fourth-quarter results that met EPS and beat revenue estimates but left investors concerned about the outlook, prompting a sharp intraday sell-off.
Morgan Stanley increased its price objective for Kornit Digital Ltd. (KRNT) to $17.00 from $15.00 while maintaining an Equalweight rating. The new target remains below the stock's recent trading level of $17.68. The firm cited "clear progress" in the company’s recent operating results, including stronger execution, accelerating impressions growth a…
BTIG lowered its price objective on Unity Software (U) to $41 from $60 while keeping a Buy rating following the company’s decision to discontinue its ironSource advertising operations. The new target remains materially higher than the current share price, and the analyst firm highlights a tradeoff between near-term revenue headwinds and improved pr…
KeyBanc Capital Markets increased its price objective for WESCO International to $340 from $304 while retaining an Overweight rating. The firm tempered its fiscal 2026 EPS estimates but raised the target to reflect what it describes as a potentially conservative company outlook. WESCO posted mixed fourth-quarter results, missing adjusted EPS expect…
